NSC |
Compound |
Enrichment |
Correlation |
NSC 59220 |
[[5-(5-fluoro-2,4-dioxopyrimidin-1-yl)-3, 4-dihydroxyoxolan-2-yl]methoxy-ydroxyphosphoryl] [3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] hydrogen phosphate, disodium salt |
0.000100168541082771 |
0.46303752 |
NSC 753221 |
3-Hydroxy-10-fluoro-5.6-dihydro-6-imino-isoindolo[2,1a]quinoxaline |
0.00012706483944704 |
0.21674517 |
NSC 668254 |
Null |
0.000209334878795459 |
0.26574498 |
NSC 303861 |
L-Cysteine analog |
0.000216242727122389 |
0.31654864 |
NSC 351521 |
Ethanesulfonic acid, 2-hydroxy-, compd. with 6-[(2,5-dimethoxyphenyl)methyl]-5-methylpyrido[2,3-d] pyrimidine-2,4-diamine (1:1) |
0.000216242727122389 |
0.36787676 |
NSC 629229 |
Null |
0.000216242727122389 |
0.03554739 |
NSC 752464 |
methyl 2-((S,3Z)-6-((E)-1-hydroxy-3-phenylallylidene)-5-oxocyclohex-3-enyl)acetate |
0.000260156221906648 |
0.45655968 |
NSC 4114 |
Morpholinium-N-oxydiethylenedithiocarbamate |
0.000260156221906649 |
0.36619243 |
NSC 208652 |
2,4-Quinazolinediamine, 5-chloro-6-[[(3,4-dichlorophenyl)amino]methyl]- |
0.000374267341249421 |
0.42259868 |
NSC 695945 |
Null |
0.000432107380838963 |
0.40235655 |